 |
|
A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
The Honolulu-Asia Aging Study
Robert Stewart, MD;
Kamal Masaki, MD;
Qian-Li Xue, PhD;
Rita Peila, MSc;
Helen Petrovitch, MD;
Lon R. White, MD;
Lenore J. Launer, PhD
Arch Neurol. 2005;62:55-60.
ABSTRACT
Background The course of weight loss associated with dementia is unclear, particularly prior to and around the onset of the clinical syndrome.
Objective To compare the natural history of weight change from mid to late life in men with and without dementia in late life.
Design and Setting The Honolulu-Asia Aging Study, a 32-year, prospective, population-based study of Japanese American men who had been weighed on 6 occasions between 1965 and 1999 and who had been screened for dementia 3 times between 1991 and 1999.
Participants Of 1890 men (aged 77-98 years), 112 with incident dementia were compared with 1778 without dementia at the sixth examination (1997-1999).
Main Outcome Measure Weight change up to and including the sixth examination was treated as the dependent variable and estimated using a repeated measures analysis.
Results Groups with and without dementia did not differ with respect to baseline weight or change in weight from mid to late life (first 26 years’ follow-up). In the late-life examinations (final 6 years), mean age- and education-adjusted weight loss was –0.22 kg/y (95% confidence intervals, –0.26 to –0.18) in participants without dementia. Men with incident dementia at the same examination had an additional yearly weight loss of –0.36 kg (95% confidence interval, –0.53 to –0.19). This was not changed substantially with adjustment for risk factors for vascular disease or functional impairment and was significant for both Alzheimer disease and vascular dementia subtypes.
Conclusions Dementia-associated weight loss begins before the onset of the clinical syndrome and accelerates by the time of diagnosis. The potential impact on prognosis should be considered in the case of elderly persons at risk for dementia.
INTRODUCTION
Weight loss in old age is common and may be related to subclinical or clinical disease. It has long been observed that weight loss is common in Alzheimer disease (AD), but this has been documented in people who already have dementia.1-3 In AD cases, weight loss may be due to a variety of factors, including difficulties with maintaining nutritional intake and increased energy expenditure.4-5 However, neurodegenerative processes that begin before a clinical diagnosis is made may also be a primary cause of weight loss.6-7 Findings from some studies suggest that weight loss may actually start in the preclinical period of dementia.8-9 This weight loss may have important prognostic value.
The Honolulu-Asia Aging Study cohort of men was examined on 6 occasions over a period of up to 34 years. Weight was measured at all examination points, and dementia was ascertained at the 3 most recent examinations. The objective of the analysis presented in this article was to compare the natural history of weight change in men with and without incident dementia at the last study examination.
METHODS
PARTICIPANTS
The baseline sample consisted of Japanese American men, identified from selective service records, who were born between 1900 and 1919 and were living on the island of Oahu, Hawaii, in 1965. Participants were examined on 3 occasions between 1965 and 1971 as part of the Honolulu Heart Program. Of 4768 survivors, 3734 (80%) participated in a fourth examination between 1991 and 1993 as a part of the Honolulu-Asia Aging Study.10 A further 2 examinations were subsequently carried out, with participation rates among survivors of 84% and 90%, respectively (Figure 1). The mean ± SD interval between the third and fourth examinations was 19 ± 1 years (range, 16-22 years). The mean ± SD interval between the fourth and fifth examinations was 2.9 ± 0.3 years (range, 2-4 years), and that between the fifth and sixth examinations was 3.2 ± 0.4 years (range, 2-4 years). Prevalent dementia was ascertained at examination 4 and incident dementia at examinations 5 and 6. The sample for the analysis presented here consists of participants at examination 6 without dementia at previous examinations (n = 1890). All participants gave written, informed consent at each examination. Proxies gave permission for cases of dementia. The protocol was approved by the Kuakini Medical Center institutional review board.
|
|
|
|
Figure 1. Outline of the study design and examination points for participants considered in this analysis.
|
|
|
DEMENTIA CASE-FINDING AND DIAGNOSIS
The 3-stage procedure for dementia case-finding has previously been described in detail.11-12 In brief, cognitive function was measured in all participants using the 100-point Cognitive Abilities Screening Instrument13 ; scores were used to identify a subsample for further diagnostic evaluation.14 In examination 6, the cutoff was a score of less than 70 on the Cognitive Abilities Screening Instrument. The dementia evaluation in all examinations included neuropsychological investigation, a proxy interview, a neurological examination, and neuroimaging. Consensus diagnoses were made by the study neurologist and at least 2 study physicians. Dementia was diagnosed according to DSM-III-R15 criteria, probable and possible AD according to National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria,16 and vascular dementia according to California Alzheimer Disease and Treatment Centers criteria.17 The remaining subtypes included subdural hematoma, Parkinson disease, cortical Lewy body disease, Pick disease, and cause not determined.
WEIGHT AND OTHER INDEPENDENT VARIABLES
Participants were weighed at all 6 examination points in light clothing according to a standard protocol. At examination 1, participants were also asked about their weight at the time of military service (early adulthood). For descriptive analyses, body mass index (weight in kilograms divided by height in meters squared) was calculated for each examination, using the mean height for examinations 1 and 3 as the denominator. Because the association between weight change and dementia might be confounded by socioeconomic factors or comorbidity, we adjusted our analyses for several factors, most of which were ascertained up to examination 4. These included age (at entry to the study), years of formal education, history of stroke obtained through surveillance of hospital records, hypertension (previous treatment, systolic blood pressure >160 mm Hg or diastolic blood pressure >95 mm Hg), diabetes (detailed according to World Health Organization criteria), and smoking (never, previous, or current). Impaired physical function at examination 4 was defined as an inability to rise from a chair or a walking speed of 0.4 m/s or slower.18 Midlife height and weight were defined as the mean values for measurements at examinations 1-3. Depressive symptoms at examination 4 were ascertained using an 11-item version of the Centers for Epidemiologic Studies Depression Scale19 questionnaire. This was categorized by quartiles for inclusion in multivariate models with missing values included as a dummy category.20 Apolipoprotein E (APOE) genotype (presence or absence of the  4 allele) was considered as a potential modifying factor for the association between weight change and dementia.21
ANALYTICAL SAMPLE
The analytical sample consisted of 1890 men, including 112 with incident dementia at examination 6, of whom 74 had AD and 15 had vascular dementia. Weight loss was associated with attrition up to the sixth examination. Among the 3734 examination 4 participants, those who did not participate in examination 6 had a mean ± SD weight loss of –3.4 ± 6.8 kg between examinations 3 and 4 while those who participated had a mean ± SD weight loss of –1.3 ± 5.9 kg between examinations 3 and 4.
STATISTICAL ANALYSIS
Independent variables associated with weight change were investigated initially by analyzing as dependent variables mean changes in weight from mid to late life (examinations 3-4) and in late life (examinations 4-6). These were adjusted for age at examination 4 using linear regression models. Individual weight changes across the 6 examinations were analyzed as follows. To account for between-subject heterogeneity and unequal time intervals between visits, we used a random-effects model to estimate trajectories of weight change from examination 1 to examination 6.22 Random effects in this context can be interpreted as the difference in the slope of weight change between an individual and the mean slope based on the total sample. Weight was entered as the dependent variable with dementia, time, and a dementia x time interaction entered as independent variables. The coefficient for the binary dementia variable represented the difference in the intercept (ie, baseline weight) associated with dementia; the coefficient for the time variables represented the weight change over time in participants without dementia; and the coefficient for the dementia x time interaction represented the additional rate of weight change associated with dementia. Time intervals were calculated individually from examination dates. To accommodate the nonlinear trajectory of weight change from mid to late life (Figure 2), 2 straight lines were fitted with different slopes for the time variable, connected at examination 4. This allowed 2 slopes for weight change to be estimated. The first time coefficient estimated the rate of weight change from mid to late life (examinations 1-4), and the second time coefficient estimated the difference in the rate of weight change between examinations 1-4 and examinations 4-6. Hence, the sum of the 2 time coefficients measured the rate of change over the late-life examinations (examinations 4-6). Individual interaction terms between dementia and the 2 time variables were similarly summed to estimate the additional rate of weight change associated with dementia across the late-life examinations, and standard errors were calculated from the covariance matrix. Other independent variables were entered into the model to investigate confounding or mediating effects. The fully adjusted model was then repeated for dementia subtypes and was stratified for baseline age and presence/absence of the APOE 4 allele to check for effect modification.
|
|
|
|
Figure 2. A graph plotting mean previous body mass index according to incident dementia at examination 6 (1997-1999).
|
|
|
RESULTS
The age range for the cohort at the first examination was 46 to 68 years, and at the sixth examination it was 77 to 98 years. The mean ± SD midlife body mass index for examination 6 participants was 23.9 ± 2.7 kg/m2. Compared with those without dementia, incident patients at examination 6 were older, were more likely to have previously impaired physical function, and had a higher APOE 4 allele frequency but were similar in other respects (Table 1).
|
|
|
|
Table 1. Characteristics of the Cohort at Examination 6 (1997-1999): The Honolulu-Asia Aging Study
|
|
|
Age-adjusted weight change was associated with several of the independent variables measured in late life (examination 4). However, the direction of change differed according to the period analyzed (Table 2). Higher education and increased disability were associated with weight loss up to examination 4 but were not significantly associated with weight change after that point. Diabetes was associated with weight loss over both periods. Hypertension, previous smoking, and increased body mass index ascertained at examination 4 were associated with previous weight gain and subsequent weight loss. Current smoking at examination 4 was only associated with subsequent weight loss.
|
|
|
|
Table 2. Associations of Late-Life Characteristics With Previous and Subsequent Weight Change
|
|
|
There were no significant differences in weight in early adulthood between men who did and did not develop dementia at examination 6 (P = .28). Neither did these 2 groups differ in weight over the course of the 3 midlife examinations (Table 1). The estimated changes in weight for the men without dementia at examination 6, in a fully adjusted model (Table 3), were +0.01 kg/y (95% confidence interval, –0.01 to +0.02) from examinations 1-4 and –0.22 kg/y (95% confidence interval, –0.26 to –0.18) from examinations 4 to 6. However, there was an increasing difference in body mass index between participants with and without dementia over the 6 years prior to the diagnosis (Figure 2), with an additional weight loss of –0.35 kg/y in those with dementia at the end of this period compared with those without dementia (95% confidence interval, –0.52 to –0.18; P<.001) (Table 3). In a comparison of those with and without dementia, there were some differences in the pattern of weight change by dementia subtype. Men with AD lost significantly more weight over the 6 years between examinations 4 and 6 compared with those without dementia. Men with vascular dementia had significant weight gain from mid to late life but then tended to lose more weight between examinations 4 and 6 than men with AD. There were no significant interactions with age or APOE genotype. The rate of weight change was, if anything, weaker in AD cases with APOE 4 (age- and education-adjusted coefficients, –0.10 kg/y for APOE 4 and –0.36 kg/y for non–APOE 4).
|
|
|
|
Table 3. Differences in the Rate of Weight Change Between Participants With and Without Incident Dementia at Examination 6: A Comparison Between 2 Life Stages
|
|
|
The differences in weight loss between men with and without dementia were particularly marked with respect to more extreme weight loss. For example, weight loss of 5 kg or more between midlife (mean values for examinations 1 and 3) and examination 6 was present in 57% of participants with incident dementia compared with 35% of those without dementia at examination 6. Weight loss of 5 kg or more between examinations 5 and 6 was present in 30% of participants with incident dementia compared with 12% of those without.
COMMENT
Incident dementia was associated with significant previous weight loss, which was independent of a large number of potential confounding factors. A high proportion of men with dementia at examination 6 had lost at least 5 kg, which approaches 10% of average body weight for this cohort. This weight loss occurred in many cases over the 2 to 4 years prior to reaching the clinical threshold of dementia. The association was similar in AD and vascular dementia. The association between dementia and late-life weight loss (examinations 4-6) was considerably stronger than associations with the other independent variables we examined.
The time course of dementia-associated weight loss has received little research attention, particularly in mild cases detected in community-based studies. Findings from several studies suggest that weight loss occurs not only in severe cases of dementia but also in more mild cases.1-2 Results from one study suggested that this may start before the onset of the clinical syndrome, although weight data were only available for 3 time points and dementia only ascertained at the third.8 In another study, low reported body mass index predicted the onset of dementia within 5 years of follow-up but did not predict dementia over a longer follow-up period.9 The Honolulu-Asia Aging Study presented a valuable opportunity to investigate the natural history of weight loss prior to the onset of dementia. Particular advantages were the large sample size, 6 examination points, and formal screening and diagnostic procedures for dementia on 3 occasions.
Bias due to attrition is an important consideration in longitudinal studies. Weight loss is associated with increased mortality in older populations23-24 and was positively associated with attrition in this cohort. Cognitive impairment has also been found to be associated with increased mortality25 and nonresponse.26 Selective attrition is therefore more likely to have obscured than exaggerated the association between weight loss and dementia in the cohort. A limitation is that weight change is composed of a constellation of processes. For example, it is not known whether the weight loss reflected loss of fat, loss of skeletal muscle, or both. Midlife obesity was uncommon in this population, and therefore most weight loss occurred from levels within the normal range for height.
Processes underlying unexplained weight loss and frailty in older people remain poorly understood. Dementia is an important cause of weight loss,27 and our findings confirm that weight loss began before the emergence of the clinical syndrome. Early neurodegenerative changes may have a role. Reduced serotonin levels in the lateral hypothalamus associated with AD have been found,28 and hypothalamic Alzheimer pathologic features have been described,29-30 although cell loss in this region associated with aging and AD is uneven.31 These neuropathological findings may not necessarily be generalized to preclinical stages of the illness, and little research has investigated underlying mechanisms in vivo. One magnetic resonance imaging study found an association between reduced volume of the mesial temporal cortex and low body mass index in community-dwelling people with AD.6 Two studies have found that weight loss in AD is greater in APOE 4 carriers.7, 32 Impaired olfaction associated with mild AD and modified by APOE genotype has been suggested as a possible factor underlying this association.7 This would predict a stronger association between weight loss and early dementia in the presence of APOE 4. In our study, the association between AD and weight loss was, if anything, weaker in the presence of APOE 4. However, only men were included in this cohort, and previous research has found that the APOE 4 association with weight loss was only present in women.7 The same consideration may apply regarding the absent association between midlife body weight (or body mass index) and dementia, since the largest prospective study of obesity and dementia to date found a positive association only in women.33 On the other hand, in a subgroup of participants without dementia in the Framingham Study, obesity was only associated with lower cognitive function in men.34 Our results do not suggest a prospective association between obesity and dementia in men although, as previously mentioned, it should be borne in mind that levels of obesity were low in this cohort.
An important consideration arising from research in this area is the extent to which weight loss may be prevented or minimized in dementia. Poor nutrition and frailty frequently complicate later stages of dementia, causing falls, poor wound healing, and increased physical dependence. Cachexia was found to account for the increased mortality associated with people with AD compared with people without dementia in one community study.35 Forgetting to eat meals and behavioral disturbances have been identified as potentially remediable causes of weight loss in established disease.3 As far as we are aware, no interventions to reduce weight loss in people with dementia have been formally evaluated to date, although one program is in progress.36 It is not unreasonable to assume that prompt and preventative interventions are likely to have the greatest impact. The results presented here suggest that weight change and nutritional state in people with dementia should be taken seriously at least from the time of diagnosis if not at earlier stages of more mild cognitive impairment.
AUTHOR INFORMATION
Correspondence: Lenore J. Launer, PhD, Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Ave, 3C-309, Bethesda, MD 20892 (launerl{at}nia.nih.gov).
Accepted for Publication: March 12, 2004.
Author Contributions: Study concept and design: Stewart, Petrovitch, White, and Launer. Acquisition of data: Masaki, Petrovitch, and White. Analysis and interpretation of data: Stewart, Xue, Peila, and Launer. Drafting of the manuscript: Stewart. Critical revision of the manuscript for important intellectual content: Stewart, Masaki, Xue, Peila, Petrovitch, White, and Launer. Statistical analysis: Xue and Peila. Obtained funding: White. Administrative, technical, and material support: Masaki and Petrovitch. Study supervision: Launer.
Funding/Support: Dr Stewart was supported by a Research Training Fellowship in Clinical Epidemiology from the Wellcome Trust, London, United Kingdom. The Honolulu-Asia Aging Study is supported by the National Institutes of Health, Bethesda, Md: National Institute on Aging contract N01-AG-4-2149 and National Heart, Lung, and Blood Institute contract N01-HC-05102.
Author Affiliations: Institute of Psychiatry, London, United Kingdom (Dr Stewart); Pacific Health Research Institute, Honolulu, Hawaii (Drs Masaki, Petrovitch, and White); Johns Hopkins Center on Aging and Health, Baltimore, Md (Dr Xue); and Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, National Institutes of Health, Bethesda, Md (Ms Peila and Dr Launer).
REFERENCES
1. White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer’s disease. J Am Geriatr Soc. 1996;44:265-272.
WEB OF SCIENCE
| PUBMED
2. Cronin-Stubbs D, Beckett LA, Scherr PA, et al. Weight loss in people with Alzheimer’s disease: a prospective population based analysis. BMJ. 1997;314:178-179.
FREE FULL TEXT
3. White H, Pieper C, Schmader K. The association of weight change in Alzheimer’s disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46:1223-1227.
WEB OF SCIENCE
| PUBMED
4. Poehlman ET, Dvorak RV. Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr. 2000;71(suppl):650S-655S.
WEB OF SCIENCE
| PUBMED
5. Gillette-Guyonnet S, Nourhashémi F, Andrieu S, et al. Weight loss in Alzheimer’s disease. Am J Clin Nutr. 2000;71(suppl):S637-S642.
WEB OF SCIENCE
| PUBMED
6. Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer’s disease is associated with mesial temporal cortex atrophy. Neurology. 1996;46:1585-1591.
FREE FULL TEXT
7. Vanhanen M, Kivipelto M, Koivisto K, et al. APOE-epsilon4 is associated with weight loss in women with AD. Neurology. 2001;56:655-659.
FREE FULL TEXT
8. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc. 1996;44:1147-1152.
WEB OF SCIENCE
| PUBMED
9. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues J-F, Barberger-Gateau P. Body mass index and incidence of dementia: the PAQUID study. Neurology. 2003;60:117-119.
FREE FULL TEXT
10. Syme SL, Marmot MG, Kagan A, Kato H, Rhoads G. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: introduction. Am J Epidemiol. 1975;102:477-480.
FREE FULL TEXT
11. White L, Petrovitch H, Ross GW, et al. Prevalence of dementia in older Japanese-American men in Hawaii. JAMA. 1996;276:955-960.
FREE FULL TEXT
12. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49-55.
WEB OF SCIENCE
| PUBMED
13. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6:45-58.
FULL TEXT
| PUBMED
14. Lee JH, Olichney JM, Hansen LA, Hofsetter CR, Thal LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol. 2000;57:1474-1479.
FREE FULL TEXT
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939-944.
FREE FULL TEXT
17. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473-480.
FREE FULL TEXT
18. Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558-560.
FREE FULL TEXT
19. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;3:385-401.
20. Takeshita J, Masaki K, Ahmed I, et al. Are depressive symptoms a risk factor for mortality in elderly Japanese-American men? the Honolulu-Asia Aging Study. Am J Psychiatry. 2002;159:1127-1132.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
21. Havlik RJ, Izmirlian G, Petrovitch H, et al. APOE-epsilon4 predicts incident AD in Japanese-American men: the Honolulu-Asia Aging Study. Neurology. 2000;54:1526-1529.
FREE FULL TEXT
22. SAS Institute Inc. SAS Technical Report P-229. Cary, NC: SAS Institute Inc; 1992:287.
23. Reynolds MW, Fredman L, Langenberg P, Magaziner J. Weight, weight change, and mortality in a random sample of older community-dwelling women. J Am Geriatr Soc. 1999;47:1409-1414.
WEB OF SCIENCE
| PUBMED
24. Stevens J, Juhaeri, Cai J. Changes in body mass index prior to baseline among participants who are ill or who die during the early years of follow-up. Am J Epidemiol. 2001;153:946-953.
FREE FULL TEXT
25. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ. 1996;312:608-611.
FREE FULL TEXT
26. Launer LJ, Wind AW, Deeg DJH. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol. 1994;139:803-812.
FREE FULL TEXT
27. Shatenstein B, Kergoat MJ, Nadon S. Anthropometric changes over 5 years in elderly Canadians by age, gender, and cognitive status. J Gerontol A Biol Sci Med Sci. 2001;56:M483-M488.
FREE FULL TEXT
28. Sparks DL, DeKosky ST, Markesbery WR. Alzheimer’s disease: aminergic-cholinergic alterations in hypothalamus. Arch Neurol. 1988;45:994-999.
FREE FULL TEXT
29. Swaab DF, Grundke-Iqbal I, Iqbal K, Kremer HPH, Ravid R, van de Ness JAP. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer’s disease. Brain Res. 1992;590:239-249.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
30. van de Nes JA, Kamphorst W, Ravid R, Swaab DF. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer’s disease patients. Brain. 1993;116:103-115.
FREE FULL TEXT
31. Goudsmit E, Hofman MA, Fliers E, Swaab DF. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer’s disease. Neurobiol Aging. 1990;11:529-536.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
32. Jefferson MF, Burlinson S, Burns A, et al. Clinical features of dementia associated with apolipoprotein epsilon4: discrimination with a neural network genetic algorithm. Int J Geriatr Psychiatry. 2001;16:77-81.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
33. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163:1524-1528.
FREE FULL TEXT
34. Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003;27:260-268.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
35. Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Risk of death from Alzheimer’s disease in a community population of older persons. Am J Epidemiol. 1991;134:403-412.
FREE FULL TEXT
36. Rivière S, Gillette-Guyonnet S, Nourhashemi F, Vellas B. Nutrition and Alzheimer’s disease. Nutr Rev. 1999;57:363-367.
WEB OF SCIENCE
| PUBMED
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Weight Loss in the Elderly May Be a Sign of Impending Dementia
Michael Grundman
Arch Neurol. 2005;62(1):20-22.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Metabolic Syndrome and Cognitive Decline Among the Oldest Old in Okinawa: In Search of a Mechanism. The KOCOA Project
Katsumata et al.
J Gerontol A Biol Sci Med Sci 2012;67A:126-134.
ABSTRACT
| FULL TEXT
Correlates of frailty in Alzheimer's disease and mild cognitive impairment
Ni Mhaolain et al.
Age Ageing 2011;40:630-633.
FULL TEXT
Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Gorelick et al.
Stroke 2011;42:2672-2713.
ABSTRACT
| FULL TEXT
Reverse Causation and Illness-related Weight Loss in Observational Studies of Body Weight and Mortality
Flegal et al.
Am J Epidemiol 2011;173:1-9.
ABSTRACT
| FULL TEXT
Cognitive decline precedes late-life longitudinal changes in vascular risk factors
van Vliet et al.
J. Neurol. Neurosurg. Psychiatry 2010;81:1028-1032.
ABSTRACT
| FULL TEXT
Changes in Weight at the End of Life: Characterizing Weight Loss by Time to Death in a Cohort Study of Older Men
Alley et al.
Am J Epidemiol 2010;172:558-565.
ABSTRACT
| FULL TEXT
Adiposity indicators and dementia over 32 years in Sweden
Gustafson et al.
Neurology 2009;73:1559-1566.
ABSTRACT
| FULL TEXT
Association of Muscle Strength With the Risk of Alzheimer Disease and the Rate of Cognitive Decline in Community-Dwelling Older Persons
Boyle et al.
Arch Neurol 2009;66:1339-1344.
ABSTRACT
| FULL TEXT
Change in Blood Pressure and Incident Dementia: A 32-Year Prospective Study
Stewart et al.
Hypertension 2009;54:233-240.
ABSTRACT
| FULL TEXT
Predicting risk of dementia in older adults: The late-life dementia risk index
Barnes et al.
Neurology 2009;73:173-179.
ABSTRACT
| FULL TEXT
Association between late-life body mass index and dementia: The Kame Project
Hughes et al.
Neurology 2009;72:1741-1746.
ABSTRACT
| FULL TEXT
Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Fitzpatrick et al.
Arch Neurol 2009;66:336-342.
ABSTRACT
| FULL TEXT
Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study
Sabia et al.
Am J Clin Nutr 2009;89:601-607.
ABSTRACT
| FULL TEXT
Body Adiposity in Late Life and Risk of Dementia or Cognitive Impairment in a Longitudinal Community-Based Study
West and Haan
J Gerontol A Biol Sci Med Sci 2009;0:gln006v1-gln006.
ABSTRACT
| FULL TEXT
Association of Adiposity Status and Changes in Early to Mid-Adulthood With Incidence of Alzheimer's Disease
Beydoun et al.
Am J Epidemiol 2008;168:1179-1189.
ABSTRACT
| FULL TEXT
Physical frailty in older persons is associated with Alzheimer disease pathology
Buchman et al.
Neurology 2008;71:499-504.
ABSTRACT
| FULL TEXT
Changes in folate, vitamin B12 and homocysteine associated with incident dementia
Kim et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:864-868.
ABSTRACT
| FULL TEXT
Albumin, haemoglobin, BMI and cognitive performance in older adults
Ng et al.
Age Ageing 2008;37:423-429.
ABSTRACT
| FULL TEXT
Body mass index and cognitive decline in a biracial community population
Sturman et al.
Neurology 2008;70:360-367.
ABSTRACT
| FULL TEXT
Five-year mortality in relation to dementia and cognitive function in 95-year-olds
Borjesson-Hanson et al.
Neurology 2007;69:2069-2075.
ABSTRACT
| FULL TEXT
Increased visceral adipose tissue rather than BMI as a risk factor for dementia
Cereda et al.
Age Ageing 2007;36:488-491.
ABSTRACT
| FULL TEXT
Incident dementia in women is preceded by weight loss by at least a decade
Knopman et al.
Neurology 2007;69:739-746.
ABSTRACT
| FULL TEXT
Selenium Level and Cognitive Function in Rural Elderly Chinese
Gao et al.
Am J Epidemiol 2007;165:955-965.
ABSTRACT
| FULL TEXT
Measures of Adiposity and Dementia Risk in Elderly Persons
Luchsinger et al.
Arch Neurol 2007;64:392-398.
ABSTRACT
| FULL TEXT
Twenty-six-Year Change in Total Cholesterol Levels and Incident Dementia: The Honolulu-Asia Aging Study
Stewart et al.
Arch Neurol 2007;64:103-107.
ABSTRACT
| FULL TEXT
Body mass index in older persons is associated with Alzheimer disease pathology
Buchman et al.
Neurology 2006;67:1949-1954.
ABSTRACT
| FULL TEXT
Association of metabolic syndrome with Alzheimer disease: a population-based study.
Vanhanen et al.
Neurology 2006;67:843-847.
ABSTRACT
| FULL TEXT
Accelerated weight loss may precede diagnosis in Alzheimer disease.
Johnson et al.
Arch Neurol 2006;63:1312-1317.
ABSTRACT
| FULL TEXT
Relationship between Helicobacter pylori infection and Alzheimer disease
Kountouras et al.
Neurology 2006;66:938-940.
ABSTRACT
| FULL TEXT
Change in body mass index and risk of incident Alzheimer disease
Buchman et al.
Neurology 2005;65:892-897.
ABSTRACT
| FULL TEXT
Weight Loss Is Associated with Early Dementia
JWatch Psychiatry 2005;2005:7-7.
FULL TEXT
Weight Loss Is Associated with Early Dementia
JWatch General 2005;2005:4-4.
FULL TEXT
Weight Loss in the Elderly May Be a Sign of Impending Dementia
Grundman
Arch Neurol 2005;62:20-22.
FULL TEXT
|
